Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023

This report describes measures that people who are immunocompromised can take to prevent and treat COVID-19.

Immune Network

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2

PDF) Serological Responses and Predictive Factors of Booster COVID

Clinical phenotypes and outcomes associated with SARS-CoV-2

Viral and host factors associated with SARS-CoV-2 disease severity

Preventing and Treating COVID-19 in Cancer Patients: Challenges in

PDF) Airway and Oral microbiome profiling of SARS-CoV-2 infected

Vaccines, Free Full-Text

Interim guidance on the use of bivalent Omicron-containing COVID

400523 PDFs Review articles in MONOCLONAL ANTIBODIES

Characterization of SARS-CoV-2 recombinants and emerging Omicron

Predictors of SARS-CoV-2 Omicron breakthrough infection after

Viral and host factors associated with SARS-CoV-2 disease severity